Heparin Induced Thrombocytopenia: Pharmacoeconomics
Completed
Conditions studied: Heparin Induced Thrombocytopenia (HIT)
In brief
Patients at BWH receiving unfractionated heparin or enoxaparin who subsequently develop heparin induced thrombocytopenia will be identified via a computer generated report designed for the purposes of this study. Subsequently, we will compare the heparin induced thrombocytopenia rates associated with heparin and low molecular weight heparin usage as well as evaluate the economic and long-term clinical burden of heparin induced thrombocytopenia.
Key facts
- Study ID
- NCT00456001
- Run by
- Brigham and Women's Hospital
- People needed
- 200
- Starts
- 2006-07-01
- Expected to finish
- 2009-01-01
- Last updated by the study team
- 2009-03-02
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Brigham and Women's Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.